SCHEMBL31686010

SCHEMBL31686010

CNC(=O)c1ccc(NC2CCN(C(=O)OC(C)(C)C)C2)cn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 6/20 0.58
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.52
NPC1 O15118 1/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MEN1 O00255 1/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
BTK Q06187 1/20 0.47
PARP1 P09874 3/20 0.47
PARP2 Q9UGN5 3/20 0.47
PIK3CD O00329 1/20 0.46
GPR119 Q8TDV5 3/20 0.46
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
PTPN2 P17706 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25215675 0.91 USP30 (0.49) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL31686045 0.88 ALDH1A1 (0.56) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL27177190 0.83 PLA2G1B (0.51) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL30089008 0.83 PLA2G1B (0.51) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL27177244 0.83 GPR119 (0.50) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL29220856 0.80 GPR119 (0.48) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL6210547 0.80 ALDH1A1 (0.67) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL29148533 0.80 USP30 (0.48) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL30849217 0.80 USP30 (0.48) USP30ALDH1A1MAPTNPC1MAPK1
SCHEMBL29148532 0.80 USP30 (0.48) USP30ALDH1A1MAPTNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289814-A1 COMPOUNDS AS PARP1 INHIBITIORS NINGBO NEWBAY TECH DEVELOPMENT CO LTD (CN) 2025-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289814-A1 COMPOUNDS AS PARP1 INHIBITIORS PARP1, PARP11, PARP12 USP30 1745/4885ALDH1A1 434/4885MAPT 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.